Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 3 Cisplatin 2 glucarpidase 1 exemestane 1 apraglutide 1 Therapeutics 1 Surveys and Questionnaires 1 Quercetin 1 Methotrexate 1 Leuprolide 1 Leucovorin 1 Letrozole 1 Hydroxychloroquine 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Fibroblast Growth Factor 7 1 Fentanyl 1 Curcumin 1 Bupropion 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Fentanyl × Other × Clear all

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡